Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): A clinicopathological study of 205 Japanese patients

Brain

Volumn 126, Issue 1, 2003, Pages 134-151

  Hattori, Naoki ^a   Yamamoto, Masahiko ^a   Yoshihara, Tsuyoshi ^a   Koike, Haruki ^a   Nakagawa, Masanori ^b   Yoshikawa, Hiroo ^c   Ohnishi, Akio ^d   Hayasaka, Kiyoshi ^e   Onodera, Osamu ^f   Baba, Masayuki ^g   Yasuda, Hitoshi ^h   Saito, Toyokazu ⁱ   Nakashima, Kenji ^j   Kira, Jun ichi ^k   Kaji, Ryuji ^l   Oka, Nobuyuki ^m   Sobue, Gen ^a   Akiguchi, Ichiro ⁿ   Sakota, Saburo ⁿ   Matsumura, Kiichiro ⁿ   Onodera, Satoshi ⁿ   Ikeda, Shu ichi ⁿ   Yamamura, Takashi ⁿ   Ando, Yukio ⁿ   Nakazato, Masamitsu ⁿ   Ikenaka, Kazuhiro ⁿ   Wada, Keiji ⁿ   Watabe, Kazuhiko ⁿ   Ando, Eiko ⁿ   more..

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e YAMAGATA UNIVERSITY   (Japan)

^f NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^g HIROSAKI UNIVERSITY   (Japan)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOTTORI UNIVERSITY   (Japan)

^k KYUSHU UNIVERSITY   (Japan)

^l UNIVERSITY OF TOKUSHIMA   (Japan)

^m HYOGO COLLEGE OF MEDICINE   (Japan)

ⁿ NONE

more..

Author keywords

Charcot Marie Tooth disease; Cx32; MPZ; PMP22

Indexed keywords

CONNEXIN 32; MYELIN PROTEIN; MYELIN PROTEIN ZERO; PERIPHERAL MYELIN PROTEIN 22; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DEMYELINATION; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FEMALE; GENE MUTATION; GENETIC CODE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MUSCLE ACTION POTENTIAL; MUSCLE STRENGTH; NERVE CONDUCTION; NERVE FIBER; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL;

ACTION POTENTIALS; ADULT; AGE OF ONSET; AXONS; CHARCOT-MARIE-TOOTH DISEASE; CHI-SQUARE DISTRIBUTION; CONNEXINS; ELECTROMYOGRAPHY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE, SKELETAL; MUTATION; MYELIN P0 PROTEIN; MYELIN PROTEINS; NEURAL CONDUCTION; STATISTICS, NONPARAMETRIC; SURAL NERVE;

EID: 0037224513     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg012     Document Type: Article

References (79)

1. Baxter RV, Ben Othmane K, Rochelle JM, Stajich JE, Hulette C, Dew-Knight S, et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nature Genet 2002; 30: 21-2.
2. Berciano J, Combarros O, Figols J, Calleja J, Cabello A, Silos I, et al. Hereditary motor and sensory neuropathy type II. Clinicopathological study of a family. Brain 1986; 109: 897-914.
3. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, et al. Connexin mutation in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 2039-42.
4. Bird TD, Kraft GH, Lipe HP, Kenney KL, Sumi SM. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study. Ann Neurol 1997; 41: 463-9.
5. Birouk N, Gouider R, LeGuern E, Gugenheim M, Tardieu S, Maisonobe T, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997; 120: 813-23.
6. Birouk N, LeGuern E, Maisonobe T, Rouger H, Gouider R, Tardieu S, et al. X-linked Charcot-Marie-Tooth disease with connexin32 mutations. Clinical and electrophysiologic study. Neurology 1998; 50: 1074-82.
7. Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, Berry K, et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002; 51: 190-201.
8. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nature Genet 2000; 25: 17-9.
9. Bradley WG, Madrid R, Davis CJ. The peroneal muscular atrophy syndrome. J Neurol Sci 1977; 32: 123-36.
10. Buchthal F, Behse F. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 1977; 100: 41-66.
11. Chapon F, Latour P, Diraison P, Schaeffer S, Vandenberghe A. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 1999; 66: 779-82.
12. Cuesta A, Pedrola L, Sevilla T, Garcia-Planells J, Chumillas MJ, Mayordomo F, et al. The gene encoding ganglioside-induced differentiation-associated protein1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nature Genet 2002; 30: 22-5.
13. De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Lofgren A, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 1999; 122: 281-90.
14. De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disease type 2) and mouse. Am J Hum Genet 2002; 70: 726-36.
15. de Waegh S, Brady ST. Altered slow axonal transport and regeneration in myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci 1990; 10: 1855-65.
16. de Waegh SM, Lee VM, Brady ST. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992; 68: 451-63.
17. Dubourg O, Tardieu S, Birouk N, Gouider R, Leger JM, Maisonobe T, et al. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain 2001a; 124: 1958-67.
18. Dubourg O, Tardieu S, Birouk N, Gouider R, Leger JM, Maisonobe T, et al. The frequency of 17p11.2 duplication and Connexin 32 mutations in 282 Charcot-Marie-Tooth families in relation to the mode of inheritance and motor nerve conduction velocity. Neuromuscul Disord 2001b; 11: 458-63.
19. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968; 18: 603-18.
20. Dyck PJ, Karnes JL, Lambert EH. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989; 39: 1302-8.
21. Dyck PJ, Giannini C, Lais A. Pathologic alterations of nerves. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders; 1993. p. 514-95.
22. Gabreels-Festen AA, Hoogendijk JE, Meijerink PH, Gabreels FJ, Bolhuis PA, van Beersum S, et al. Two divergent types of nerve pathology in patients with different PO mutations in Charcot-Marie-Tooth disease. Neurology 1996; 47: 761-5.
23. Garcia CA, Malamut RE, England JD, Parry GS, Liu P, Lupski JR. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 1995; 45: 2090-3.
24. Garcia A, Combarros O, Calleja J, Berciano J. Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 1998; 50: 1061-7.
25. Guilbot A, Williams A, Ravise N, Verny C, Brice A, Sherman DL, et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001; 10: 415-21.
26. Gutierrez A, England JD, Sumner AJ, Ferer S, Warner LE, Lupski JR, et al. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 2000; 23: 182-8.
27. Hahn AF, Brown WF, Koopman WJ, Feasby TE. X-linked dominant hereditary motor and sensory neuropathy. Brain 1990; 113: 1511-25.
28. Hahn AF, Ainsworth PJ, Bolton CF, Bilbao JM, Vallat JM. Pathological findings in the x-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol (Berl) 2001; 101: 129-39.
29. Harding AE. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. [Review]. Brain 1995; 118: 809-18.
30. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980; 103: 259-80.
31. Hattori N, Ichimura M, Nagamatsu M, Li M, Yamamoto K, Kumazawa K, et al. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 1999; 122: 427-39.
32. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutation of the myelin PO gene. Nature Genet 1993; 5: 31-4.
33. Ikegami T, Ikeda H, Chance PF, Kiyosawa H, Yamamoto M, Sobue G, et al. Facilitated diagnosis of the CMT1A duplication in chromosome 17p11.2-12: analysis with a CMT1A-REP repeat probe and photostimulated luminescence imaging. Hum Mutat 1997; 9: 563-6.
34. Ionasescu V, Searby C, Ionasescu R. Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mol Genet 1994; 3: 355-8.
35. Ionasescu VV, Searby C, Ionasescu R, Neuhaus IM, Werner R. Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 1996; 47: 541-4.
36. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 1993a; 43: 1806-8.
37. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 1993b; 43: 2664-7.
38. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 2000; 67: 47-58.
39. Kamholz J, Menichella D, Jani A, Garbern J, Lewis RA, Krajewski KM, et al. Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. [Review]. Brain 2000; 123: 222-33.
40. Killian JM, Tiwari PS, Jacobson S, Jackson RD, Lupski JR. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 1996; 19: 74-8.
41. Koike H, Mori K, Misu K, Hattori N, Ito H, Hirayama M, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001; 56: 1727-32.
42. Kovach MJ, Lin JP, Boyadjiev S, Campbell K, Mazzeo L, Herman K, et al. A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. Am J Hum Genet 1999; 64: 1580-93.
43. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000; 123: 1516-27.
44. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66: 219-32.
45. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998; 50: 1397-401.
46. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nature Genet 1992; 1: 176-9.
47. Mersiyanova IV, Perepelov AV, Polyakov AV, Simikov VF, Dadali EL, Oparin RB, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000; 67: 37-46.
48. Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan: clinicopathological and genetic features. Brain 1999; 122: 1951-62.
49. Misu K, Yoshihara T, Shikama Y, Awaki E, Yamamoto M, Hattori N, et al. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry 2000; 69: 806-11.
50. Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001; 30: 355-68.
51. Nelis E, Van Broeckhoven C, De Jonghe P, Lofgren A, Vandenberghe A, Latour P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996; 4: 25-33.
52. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993; 43: 2558-64.
53. Nicholson GA, Yeung L, Corbett A. Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth families: ten novel mutations. Neurology 1998; 51: 1412-6.
54. Paraskevas GP, Panousopoulou A, Karandreas N, Piperos P, Lygidakis C, Papageorgiou C. Correlation between denervation activity and compound muscle action potential amplitude in hereditary motor and sensory neuropathy I and II. Electromyogr Clin Neurophysiol 1998; 38: 343-7.
55. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nature Genet 1992; 1: 159-65.
56. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type la (CMT la). The HMSN Collaborative Research Group. Neuromuscul Disord 1991; 1: 93-7.
57. Reilly MM. Classification of the hereditary motor and sensory neuropathies. [Review]. Curr Opin Neurol 2000; 13: 561-4.
58. Sahenk Z, Chen L, Mendell JR. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 1999; 45: 16-24.
59. Sancho S, Magyar JP, Aguzzi A, Suterl U. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 1999; 122: 1563-77.
60. Sander S, Nicholson GA, Ouvrier RA, McLeod JG, Pollard JD. Charcot-Marie-Tooth disease: histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1). Muscle Nerve 1998; 21: 217-25.
61. Sander S, Ouvrier RA, Mcleod JG, Nicholson GA, Pollard JD. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry 2000; 68: 483-8.
62. Scherer S. Axonal pathology in demyelinating diseases [letter]. Ann Neurol 1999; 45: 6-7.
63. Scherer SS, Fischbeck KH. Is CMTX an axonopathy? [letter]. Neurology 1999; 52: 432-3.
64. Senderek J, Hermanns B, Bergmann C, Boroojerdi B, Bajbouj M, Hungs M, et al. X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations (1). J Neurol Sci 1999; 167: 90-101.
65. Smith TW, Bhawan J, Keller RB, DeGirolami U. Charcot-Marie-Tooth disease associated with hypertrophic neuropathy: a neuropathologic study of two cases. J Neuropathol Exp Neurol 1980; 39: 420-40.
66. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A, et al. X-Linked recessive bulbospinal neuronopathy: a clinicopathological study. Brain 1989; 112: 209-32.
67. Sobue G, Nakao N, Murakami K, Yasuda T, Sahashi K, Mitsuma T, et al. Type I familial amyloid polyneuropathy. A pathological study of the peripheral nervous system. Brain 1990; 113: 903-19.
68. Sobue G, Li M, Terao S, Aoki S, Ichimura M, leda T, et al. Axonal pathology in Japanese Guillain-Barré syndrome: a study of 15 autopsied cases. Neurology 1997; 48: 1694-700.
69. Tabaraud F, Lagrange E, Sindou P, Vandenberghe A, Levy N, Vallat JM. Demyelinating X-linked Charcot-Marie-Tooth disease: unusual electrophysiological findings. Muscle Nerve 1999; 22: 1442-7.
70. Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RH, Bradley JL, et al. The phenotypic manifestations of chromosome 17pl 1.2 duplication. Brain 1997; 120: 465-78.
71. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet 1992; 1: 171-5.
72. Vital A, Ferrer X, Lagueny A, Vandenberghe A, Latour P, Goizet C, et al. Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutations. J Peripher Nerv Syst 2001; 6: 79-84.
73. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nature Genet 1998; 18: 382-4.
74. Watson DF, Nachtman FN, Kuncl RW, Griffin JW. Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot-Marie-Tooth disease type I. Neurology 1994; 44: 2383-7.
75. Yamamoto M, Yasuda T, Hayasaka K, Ohnishi A, Yoshikawa H, Yanagihara T, et al. Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP. Hum Genet 1997; 99: 151-4.
76. Yamamoto M, Keller MP, Yasuda T, Hayasaka K, Ohnishi A, Yoshikawa H, et al. Clustering of CMT1A duplication breakpoints in a 700 bp interval of the CMT1A-REP repeat. Hum Mutat 1998; 11: 109-13.
77. Yoshihara T, Yamamoto M, Doyu M, Mis KI, Hattori N, Hasegawa Y, et al. Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot-Marie-Tooth disease. Hum Mutat (Online) 2000; 16: 177-8.
78. Yoshihara T, Kanda F, Yamamoto M, Ishihara H, Misu K, Hattori N, et al. A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot-Marie-Tooth disease type 1. J Neurol Sci 2001; 184: 149-53.
79. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105: 587-97.